Topics

FDA approves treatment for the ‘world’s deadliest infectious disease’

11:12 EDT 15 Aug 2019 | in-PharmaTechnologis

FDA approves the third anti-TB drug in more than 40 years after the compound showed significantly higher success rates in patients with multi drug-resistant and extensively drug-resistant TB.

Original Article: FDA approves treatment for the ‘world’s deadliest infectious disease’

NEXT ARTICLE

More From BioPortfolio on "FDA approves treatment for the ‘world’s deadliest infectious disease’"

Quick Search